Two Sigma Securities, LLC Moleculin Biotech, Inc. Transaction History

Two Sigma Securities, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.54 - $0.95 $219 - $385	-406 Reduced 3.0%	13,115 $7,000
Q1 2023 May 15, 2023	BUY	$0.9 - $1.34 $12,168 - $18,118	13,521 New	13,521 $12,000
Q1 2022 May 16, 2022	SELL	$1.23 - $1.9 $27,274 - $42,130	-22,174 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.64 - $2.83 $36,365 - $62,752	22,174 New	22,174 $41,000
Q2 2021 Aug 16, 2021	SELL	$3.21 - $4.06 $87,389 - $110,529	-27,224 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$3.7 - $6.42 $100,728 - $174,778	27,224 New	27,224 $111,000

3.35K

Ticker MBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,606,700
Market Cap $48.6M
Description
Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs....

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.